SCHEMBL21373140

SCHEMBL21373140

Cc1cc(C)c(S(=O)(=O)n2cc(B3OC(C)(C)C(C)(C)O3)cc2C(=O)O)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 8/20 0.42
▸ MAPT P10636 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ GAA P10253 2/20 0.34
▸ ALDH1A1 P00352 3/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ F2 P00734 2/20 0.32
▸ PRSS1 P07477 2/20 0.32
▸ PRSS2 P07478 2/20 0.32
▸ PRSS3 P35030 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ F11 P03951 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4798623 0.87 RAPGEF4 (0.39) RAPGEF4MAPTNPSR1HTTTDP1
SCHEMBL16207740 0.86 CA1 (0.37) RAPGEF4F2PRSS1PRSS2PRSS3
SCHEMBL4441787 0.74 CYP2C9 (0.41) MAPTGAAKMT2AMEN1KDM4E
SCHEMBL15866395 0.68 CA1 (0.36) F2PRSS1PRSS2PRSS3F11
SCHEMBL14487909 0.67 ELANE (0.38) RAPGEF4NPSR1ALDH1A1KMT2AKDM4E
SCHEMBL28897192 0.67 ELANE (0.38) RAPGEF4NPSR1KMT2AMEN1KDM4E
SCHEMBL3030889 0.65 HIF1A (0.37) MAPTNPSR1TDP1GAAALDH1A1
SCHEMBL16318681 0.65 ALDH1A1 (0.37) RAPGEF4GAAALDH1A1F2PRSS1
SCHEMBL16034457 0.65 TPMT (0.52) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL3232840 0.64 USP30 (0.38) F2PRSS1PRSS2PRSS3F11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305776-B1 PYRROLE COMPOUNDS AS INHIBITORS OF ERK PROTEIN KINASES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS VERTEX PHARMA (US) 2019-09-25 — — EP disclosed
Send feedback